Arrowhead Pharmaceuticals, Inc. (ARWR)

67.07 -2.52 (-3.62%) USD  |  NASDAQ  |  Jan 23, 16:00
67.07 0.00 (0.00%) After-Hours: 16:57
More

Arrowhead Pharmaceuticals Change in Payables and Accrued Expense (Quarterly)

Change in Payables and Accrued Expense (Quarterly) Chart

View Change in Payables and Accrued Expense (Quarterly) for ARWR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Payables and Accrued Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Payables and Accrued Expense (Quarterly) Benchmarks

View Change in Payables and Accrued Expense (Quarterly) Benchmarks
Start Trial
Sarepta Therapeutics, Inc. Upgrade
Eli Lilly & Co. --
Ionis Pharmaceuticals, Inc. Upgrade
Cidara Therapeutics, Inc. Upgrade
Celcuity, Inc. Upgrade